PP_1170x120_10-25-21

Par Specialty Pharmaceutical

Par ships authorized generic of Megace ES

CHESTNUT RIDGE, N.Y. — Par Pharmaceutical Companies Inc. has released an authorized generic version of Par Specialty Pharmaceutical’s Megace ES oral suspension. Megace ES oral suspension (megestrol acetate) is a progestin indicated for the treatment of anorexia, cachexia or an unexplained significant weight loss in patients diagnosed with AIDS. The generic product is available in

Adheris Health